Remarkably, an increased expression of anti‐inflammatory cytokines IFN‐α and IL‐13 was observed in those T2DM patients, which may help mitigate the damage caused by an elevated pro‐inflammatory response.83 The gene discussed is IL13; the disease is type 2 diabetes mellitus.